Transgene (OTCMKTS:TRGNF) Stock Price Breaks Above Fifty Day Moving Average – What’s Next?

Transgene SA (OTCMKTS:TRGNF – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $0.78 and traded as high as $0.80. Transgene shares last traded at $0.80, with a volume of 1,600 shares trading hands.

Transgene Stock Performance

The business has a 50 day moving average of $0.78 and a 200-day moving average of $0.87.

About Transgene

(Get Free Report)

Transgene is a French biotechnology company that develops immunotherapies, with a primary focus on treatments for cancer. Its research centers on therapeutic vaccines and oncolytic viruses—engineered viruses designed to target tumors and stimulate an immune response. The company’s pipeline includes candidates using viral-vector platforms, including personalized approaches intended to tailor treatment to the characteristics of an individual patient’s tumor. Transgene advances its programs through research and clinical development, often working with academic and industry partners.

Further Reading

Receive News & Ratings for Transgene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transgene and related companies with MarketBeat.com's FREE daily email newsletter.